50090-6180Level 3
MENQUADFI (NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN)
**Product type:** Vaccine
**Active ingredient:** NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN; NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN; NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN; NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN
**Strength:** 10; 10; 10; 10 ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL
**Dosage form:** Injection, Solution
**Route:** Intramuscular
**Labeler:** A-S Medication Solutions
**Marketing category:** BLA (BLA125701)
GET
/api/v1/systems/ndc_fda/nodes/50090-6180Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.